Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-006208
Filing Date
2021-05-06
Accepted
2021-05-06 16:07:36
Documents
81
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q coll-20210331x10q.htm   iXBRL 10-Q 1548186
2 EX-31.1 coll-20210331xex31d1.htm EX-31.1 13404
3 EX-31.2 coll-20210331xex31d2.htm EX-31.2 13428
4 EX-32.1 coll-20210331xex32d1.htm EX-32.1 7713
5 EX-32.2 coll-20210331xex32d2.htm EX-32.2 7551
6 GRAPHIC coll-20210331x10q001.jpg GRAPHIC 5960
  Complete submission text file 0001558370-21-006208.txt   7827705

Data Files

Seq Description Document Type Size
7 EX-101.SCH coll-20210331.xsd EX-101.SCH 65150
8 EX-101.CAL coll-20210331_cal.xml EX-101.CAL 67075
9 EX-101.DEF coll-20210331_def.xml EX-101.DEF 239480
10 EX-101.LAB coll-20210331_lab.xml EX-101.LAB 551929
11 EX-101.PRE coll-20210331_pre.xml EX-101.PRE 427846
12 EXTRACTED XBRL INSTANCE DOCUMENT coll-20210331x10q_htm.xml XML 1428545
Mailing Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072
Business Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072 781-713-3699
COLLEGIUM PHARMACEUTICAL, INC (Filer) CIK: 0001267565 (see all company filings)

EIN.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37372 | Film No.: 21897754
SIC: 2834 Pharmaceutical Preparations